D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$986M |
| 2 |
Sea Limited
SE
|
+$480M |
| 3 |
Snowflake
SNOW
|
+$441M |
| 4 |
Citigroup
C
|
+$422M |
| 5 |
Oracle
ORCL
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$575M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Mastercard
MA
|
+$506M |
| 4 |
Walt Disney
DIS
|
+$447M |
| 5 |
Alibaba
BABA
|
+$434M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.34% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Financials | 7.38% |
| 4 | Healthcare | 6.92% |
| 5 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1751
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $8.04M | 0.01% |
+153,587
| New | +$6.45M |
|
|
LAC
1752
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $8.04M | 0.01% |
275,975
+246,686
| +842% | +$7.38M |
|
1753
Thomson Reuters
TRI
$42.7B
| $8.03M | 0.01% |
63,653
-133,016
| -68% | -$16.6M |
|
|
GGMC
1754
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
| $8.03M | 0.01% |
824,053
+405,812
| +97% | +$3.95M |
|
1755
Calidi Biotherapeutics
CLDI
$2.11M
| $8.02M | 0.01% |
+6,798
| New | +$8.01M |
|
|
FCAX
1756
DELISTED
Fortress Capital Acquisition Corp.
FCAX
| $8.01M | 0.01% |
820,293
+75,664
| +10% | +$740K |
|
1757
Talos Energy
TALO
$2.36B
| $8M | 0.01% |
815,768
-187,480
| -19% | -$2.14M |
|
|
LGF.B
1758
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $7.99M | 0.01% |
519,020
-583,761
| -53% | -$8.18M |
|
|
DFS
1759
CALL
DELISTED
Discover Financial Services
DFS
| $7.99M | 0.01% |
69,100
+3,200
| +5% | +$379K |
|
1760
Alarm.com
ALRM
$2.65B
| $7.98M | 0.01% |
94,091
-6,349
| -6% | -$519K |
|
1761
Lightspeed Commerce
LSPD
$1.35B
| $7.96M | 0.01% |
197,095
+188,800
| +2,276% | +$12.9M |
|
|
APR
1762
DELISTED
Apria, Inc. Common Stock
APR
| $7.96M | 0.01% |
244,306
+153,972
| +170% | +$4.99M |
|
1763
Healthpeak Properties
DOC
$15.5B
| $7.96M | 0.01% |
220,468
-33,866
| -13% | -$1.17M |
|
1764
RLJ Lodging Trust
RLJ
$1.9B
| $7.92M | 0.01% |
568,599
+196,133
| +53% | +$2.76M |
|
|
VTIQ
1765
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
| $7.92M | 0.01% |
812,637
+5,430
| +0.7% | +$53.1K |
|
1766
Upbound Group
UPBD
$1.2B
| $7.91M | 0.01% |
164,561
+71,394
| +77% | +$3.57M |
|
1767
Allogene Therapeutics
ALLO
$604M
| $7.91M | 0.01% |
529,815
+507,107
| +2,233% | +$8.95M |
|
|
OLPX
1768
DELISTED
Olaplex Holdings
OLPX
| $7.89M | 0.01% |
+271,028
| New | +$7.19M |
|
1769
CALL
C3.ai
AI
$1.37B
| $7.89M | 0.01% |
252,600
+61,600
| +32% | +$2.49M |
|
|
COOL
1770
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
| $7.88M | 0.01% |
804,410
+135,093
| +20% | +$1.32M |
|
1771
Edgewell Personal Care
EPC
$1.28B
| $7.88M | 0.01% |
172,384
-28,392
| -14% | -$1.15M |
|
1772
CALL
Applied Materials
AMAT
$410B
| $7.87M | 0.01% |
50,000
+13,800
| +38% | +$2M |
|
1773
CALL
Rio Tinto
RIO
$150B
| $7.87M | 0.01% |
117,500
+500
| +0.4% | +$32.4K |
|
1774
Alnylam Pharmaceuticals
ALNY
$37.2B
| $7.86M | 0.01% |
46,340
+13,277
| +40% | +$2.47M |
|
1775
PUT
GoodRx Holdings
GDRX
$1.03B
| $7.84M | 0.01% |
240,000
-93,100
| -28% | -$3.75M |
|
Similar funds
D.E. Shaw & Co's Q4 2021 Portfolio in Review
As of Q4 2021, D.E. Shaw & Co held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co's Q4 2021 filing shows 1,033 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- D.E. Shaw & Co's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
- D.E. Shaw & Co added most to Sea Limited in Q4 2021, an estimated $480M increase.
- D.E. Shaw & Co's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
- D.E. Shaw & Co fully exited Aon in Q4 2021, selling an estimated $179M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
- D.E. Shaw & Co opened 1,033 new positions and closed 616 in Q4 2021.
- D.E. Shaw & Co's portfolio value rose 8.8% quarter-over-quarter to $121B.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.